| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/03/2004 | EP0842200B1 High metathesis activity ruthenium and osmium metal carbene complexes |
| 03/03/2004 | EP0792275B1 Improved antiviral prodrugs |
| 03/03/2004 | EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide |
| 03/03/2004 | CN1479721A Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1479712A Ketone compounds and compositions for cholesterol management and related uses |
| 03/03/2004 | CN1478784A New technology for preparating N-phosphono methyl glycine |
| 03/03/2004 | CN1478783A Inositol polyphosphate ester derivative and its using method |
| 03/03/2004 | CN1140533C Preparation of phosphabenzene compounds |
| 03/03/2004 | CN1140532C Process for preparing bisphosphines |
| 03/03/2004 | CN1140531C Method for manufacturing phosphine compound |
| 03/03/2004 | CN1140506C Method for preparing guanidine derivative |
| 03/03/2004 | CN1140346C Process for preparing carboxylic acid salts and catalyst useful in such process |
| 03/02/2004 | US6700007 Method for preparing alkoxyamines from nitroxides |
| 03/02/2004 | US6699978 Linker nucleoside, and production and use of the same |
| 03/02/2004 | US6699975 Fluorescent quenching detection reagents and methods |
| 03/02/2004 | US6699952 Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof |
| 03/02/2004 | US6699912 Producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from aqueous solution and dissolving magma into a salting-in mixture to form semitransparent colloidal solution |
| 03/02/2004 | US6699910 Ketone compounds and compositions for cholesterol management and related uses |
| 03/02/2004 | US6699851 Amides of polyunsaturated fatty acids with cysteamine-s-phosphate antitumor agents |
| 03/02/2004 | US6699682 Assay for inhibitors of fatty-acid amide hydrolase |
| 03/02/2004 | US6699499 Amphiphilic materials and liposome formulations thereof |
| 02/26/2004 | WO2004016710A1 Compounds comprising phosphorus-containing metal complexes |
| 02/26/2004 | WO2004016683A1 Antistatic and antidust agents, compositions thereof, and methods of manufacture |
| 02/26/2004 | WO2004016631A1 Phosphonium and imidazolium salts and methods of their preparation |
| 02/26/2004 | WO2004016630A1 Organophosphorous compounds having polysulfide bridge |
| 02/26/2004 | WO2003074008A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 02/26/2004 | WO2003059898A3 Eponemycin and epoxomicin analogs and uses thereof |
| 02/26/2004 | US20040039212 Sphingolipid derivatives and their methods of use |
| 02/26/2004 | US20040039189 Solid phase synthesis; linkers allow for regeneration of surfaces without damage |
| 02/26/2004 | US20040039154 The epoxy resin includes a compound having two or more epoxy groups in one molecule, a compound having two or more phenolic hydroxy groups, in a molecule, and a trisubstituted phosphoniophenolate or salt as a curing accelerator |
| 02/26/2004 | US20040038987 Novel cyclic diamine compounds and medicine containing the same |
| 02/26/2004 | US20040038943 Indole and benzimidazole 15-lipoxygenase inhibitors |
| 02/26/2004 | US20040035293 Melt point is < 100 degrees c; provides distinct selectivities and reactivities because they are made of ions rather than molecules |
| 02/26/2004 | DE3921022B4 Mitomycinphosphatderivat und pharmazeutisches Mittel, das diese Verbindung als Antitumorwirkstoff enthält Mitomycinphosphatderivat and pharmaceutical agent containing this compound as an antitumor agent |
| 02/26/2004 | CA2495755A1 Compounds comprising phosphorus-containing metal complexes |
| 02/25/2004 | EP1391952A2 Salts of pentacyclic or tetrapentaline derived anions, and their uses as ionic conductive materials |
| 02/25/2004 | EP1391448A1 Optically active diamines and their use in catalytic processes |
| 02/25/2004 | EP1390373A1 Process for the preparation of 4-amino-1-hydroxybutylidene-1, 1-biphosphonic acid |
| 02/25/2004 | EP1390343A1 Novel retinoid derivatives and methods for producing said compounds and an anti-cancer pharmaceutical composition comprising said compounds |
| 02/25/2004 | EP1390340A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/25/2004 | EP1390081A2 Therapeutic and diagnostic compounds, compositions, and methods |
| 02/25/2004 | EP1389970A2 Compositions and methods of double-targeting virus infections and cancer cells |
| 02/25/2004 | EP1236735B1 Benzamidine derivatives |
| 02/25/2004 | EP1235833B1 Analogs of (1s, cis)-4-(2-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral |
| 02/25/2004 | EP1173448B1 Stable solutions of rare earth tris (organophosphorus-derivatives) |
| 02/25/2004 | EP1144346B1 Method for preparing beta-phosphorous nitroxide radicals |
| 02/25/2004 | EP1140807B1 Method for preparing nitroxides |
| 02/25/2004 | EP1055008B1 Hydrogen-free regeneration of dithiophosphorus metal extractants |
| 02/25/2004 | CN1478094A Process and ester derivatives for preparing cephalosporins |
| 02/25/2004 | CN1476783A Method for continuously extracting egg yolk oil and egg yolk lecithin by using supercritical CO2 extraction process |
| 02/25/2004 | CN1139597C Preparation of 9-[ 2-[ [ [di (trimethylacetoxyl) methyl] phosphoros]-methoxy-ethyl] adenine |
| 02/24/2004 | US6696608 Transfer hydrogenation process |
| 02/24/2004 | US6696602 Method for the production of phosphonomethylglycine |
| 02/24/2004 | US6696601 Bone disorders |
| 02/24/2004 | US6696597 Metathesis syntheses of pheromones or their components |
| 02/24/2004 | US6696589 Supported liquid membrane strip dispersion process for removal and recovery of one or more radionuclides or metals from a feed solution containing the radionuclides by treating with extractant |
| 02/24/2004 | US6696569 Compounds for generating chemiluminescence with a peroxidase |
| 02/24/2004 | US6696551 225Ac-HEHA and related compounds, methods of synthesis and methods of use |
| 02/24/2004 | US6696427 Use of bisphosphonates for the prevention and treatment of infectious processes |
| 02/24/2004 | US6696081 Lipids where the glycerol backbone is replaced with a carbohydrate; conjugates; drug delivery |
| 02/24/2004 | US6696036 Dehydrating washed rice bran under pressure and drying; burning at a first temperature of 350-400 degrees c. while agitating and pulverizing and burning at a second temperature of 700-1000 degrees c. for 10 60 minutes |
| 02/24/2004 | CA2250014C Asymmetric benzoxanthene dyes |
| 02/19/2004 | WO2004014927A1 Mitochondrially targeted antioxidants |
| 02/19/2004 | WO2004014926A2 Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation |
| 02/19/2004 | WO2004014925A1 Process for producing n-phosphonomethylglycine |
| 02/19/2004 | WO2004014834A1 Process for the carbonylation of ethylenically unsaturated compouds |
| 02/19/2004 | WO2004014562A2 Collecting agent for sulphidic ores, the production and use thereof |
| 02/19/2004 | WO2004014552A1 A phospha-adamantane (s) catalytic system |
| 02/19/2004 | WO2004014144A1 Process for removing sugar and/or oil from lecithin |
| 02/19/2004 | WO2003065882A3 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 02/19/2004 | WO2003059255A3 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/19/2004 | WO2003024402A3 Lpa receptor agonists and antagonists and methods of use |
| 02/19/2004 | WO2002090560A3 Process for the production of phospholipids |
| 02/19/2004 | US20040034205 Chiral (1pyrrolino) fullerene derivatives |
| 02/19/2004 | US20040034131 Antistatic and antidust agents, compositions thereof, and methods of manufacture |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034095 Low toxicity; side effect reduction |
| 02/19/2004 | US20040034080 Comprises catalytic hydroformylation/hydrocarbonylation and reductive amination using a transition metal catalyst |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | US20040033994 Use of compounds comprising a nitrogen-oxygen heterocycle |
| 02/19/2004 | US20040033988 Sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation |
| 02/19/2004 | US20040033987 Phosphorus compounds such as 1-palmitoyl-2-valproyl-glycero-3-phosphatidylcholine, used for prohylaxis of nervous system disorders such as epilepsy, migraine, bipolar disorders and pain |
| 02/19/2004 | US20040033892 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof |
| 02/19/2004 | US20040033359 Highly luminescnt color-selective nanocrystalline materials |
| 02/19/2004 | US20040033197 Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts |
| 02/19/2004 | CA2494826A1 Alkoxyamines originating from beta-phosphorylated nitroxides and use thereof in radical polymerisation |
| 02/19/2004 | CA2494173A1 Mitochondrially targeted antioxidants |
| 02/18/2004 | EP1389198A2 Process for the preparation of prostaglandins and analogues thereof |
| 02/18/2004 | EP1389174A1 Preparation and use of diols |
| 02/18/2004 | EP1294731B1 Bisphosphite compounds, the metal complexes thereof and the use of said compounds and complexes in olefin hydroformylation |
| 02/18/2004 | EP1162980B1 Pyridoxine compounds in the treatment of cardiovascular pathologies |
| 02/18/2004 | EP1100336B1 Microencapsulation formulations of cadusafos |
| 02/18/2004 | EP0918781B1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands |
| 02/18/2004 | EP0691852B1 Valproic acid covalently bonded to a lysophospholipid |
| 02/18/2004 | CN1476446A Benzodiazepine derivative |
| 02/18/2004 | CN1476424A 萘衍生物 Naphthalene Derivatives |
| 02/18/2004 | CN1138782C Method for prepn. and purification of phosphine oxide |
| 02/18/2004 | CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 02/17/2004 | US6693212 Conducting salts in electrochemical storage systems |
| 02/17/2004 | US6693210 Triphenylphosphine derivative, production process therefor, palladium complex thereof, and process for producing biaryl derivative |